Study to Assess the Efficacy and Safety of PF-06651600 in Subjects with Rheumatoid Arthritis with an Inadequate Response to Methotrexate

A Phase 2a, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multi-Center Study to Assess the
Efficacy and Safety Profile of PF-06651600 in Subjects With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to Methotrexate

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
PF-06651600
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7981006
Open Plain Language Summary Result:Click here